These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6726654)

  • 1. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
    Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal interaction between itraconazole and cimetidine.
    Karyekar CS; Eddington ND; Briglia A; Gubbins PO; Dowling TC
    J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carbamazepine metabolism by cimetidine.
    Grasela DM; Rocci ML
    Drug Metab Dispos; 1984; 12(2):204-8. PubMed ID: 6144486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
    Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cimetidine in patients with liver disease.
    González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxepin-cimetidine interaction: increased doxepin bioavailability during cimetidine treatment.
    Abernethy DR; Todd EL
    J Clin Psychopharmacol; 1986 Feb; 6(1):8-12. PubMed ID: 3950073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorption.
    Kirch W; Janisch HD; Ohnhaus EE; van Peer A
    Ther Drug Monit; 1989; 11(4):411-4. PubMed ID: 2741189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age, gender, and obesity on midazolam kinetics.
    Greenblatt DJ; Abernethy DR; Locniskar A; Harmatz JS; Limjuco RA; Shader RI
    Anesthesiology; 1984 Jul; 61(1):27-35. PubMed ID: 6742481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
    Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
    Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.